February 4, 2014 — CorTechs Labs Inc. renewed and expanded its partnership and distribution agreement with Invivo Corp. for NeuroQuant, a software solution for volumetric brain atrophy in the U.S. healthcare market.
NeuroQuan, an U.S. Food and Drug Administration (FDA) approved solution, automatically quantifies volumes of brain structures and is a key part of Invivo's DynaSuite Neuro Imaging Solution. CorTechs Labs encourages use of NeuroQuant to test for brain disorders including Alzheimer's disease, epilepsy and traumatic brain injury.
NeuroQuant is a 510(k) cleared medical device that provies quantitative analysis of MRI images of the human brain.
For more information: www.cortechs.net, www.invivocorp.com
March 13, 2026 
